2025 annual financial data
Bicara Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -155,604,000 USD and net income was -137,950,000 USD.
Operating cash flow was -106,834,000 USD.
Get free Bicara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -155,604,000 USD
- Net income
- -137,950,000 USD
- Operating cash flow
- -106,834,000 USD